Viva Biotech Holdings (FRA:VB0)

Viva Biotech Holdings Statistics

Total Valuation

FRA:VB0 has a market cap or net worth of EUR 470.82 million. The enterprise value is 503.06 million.

Market Cap	470.82M
Enterprise Value	503.06M

Important Dates

The last earnings date was Friday, November 28, 2025.

Earnings Date	Nov 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	2.11B
Shares Outstanding	n/a
Shares Change (YoY)	+48.61%
Shares Change (QoQ)	-30.21%
Owned by Insiders (%)	40.03%
Owned by Institutions (%)	1.39%
Float	1.02B

Valuation Ratios

The trailing PE ratio is 22.99 and the forward PE ratio is 7.34.

PE Ratio	22.99
Forward PE	7.34
PS Ratio	2.16
PB Ratio	1.01
P/TBV Ratio	2.83
P/FCF Ratio	18.48
P/OCF Ratio	11.27
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.33, with an EV/FCF ratio of 19.75.

EV / Earnings	24.57
EV / Sales	2.26
EV / EBITDA	9.33
EV / EBIT	18.22
EV / FCF	19.75

Financial Position

The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.30.

Current Ratio	1.76
Quick Ratio	1.22
Debt / Equity	0.30
Debt / EBITDA	2.59
Debt / FCF	5.39
Interest Coverage	5.57

Financial Efficiency

Return on equity (ROE) is 5.87% and return on invested capital (ROIC) is 2.75%.

Return on Equity (ROE)	5.87%
Return on Assets (ROA)	2.03%
Return on Invested Capital (ROIC)	2.75%
Return on Capital Employed (ROCE)	3.88%
Revenue Per Employee	104,706
Profits Per Employee	9,822
Employee Count	2,063
Asset Turnover	0.26
Inventory Turnover	4.24

Taxes

In the past 12 months, FRA:VB0 has paid 6.60 million in taxes.

Income Tax	6.60M
Effective Tax Rate	19.69%

Stock Price Statistics

The stock price has increased by +103.85% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+103.85%
50-Day Moving Average	0.26
200-Day Moving Average	0.21
Relative Strength Index (RSI)	39.60
Average Volume (20 Days)	352

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:VB0 had revenue of EUR 218.31 million and earned 20.48 million in profits. Earnings per share was 0.01.

Revenue	218.31M
Gross Profit	81.74M
Operating Income	27.17M
Pretax Income	33.51M
Net Income	20.48M
EBITDA	51.34M
EBIT	27.17M
Earnings Per Share (EPS)	0.01

Balance Sheet

The company has 107.50 million in cash and 137.43 million in debt, giving a net cash position of -29.93 million.

Cash & Cash Equivalents	107.50M
Total Debt	137.43M
Net Cash	-29.93M
Net Cash Per Share	n/a
Equity (Book Value)	464.45M
Book Value Per Share	0.22
Working Capital	89.67M

Cash Flow

In the last 12 months, operating cash flow was 41.78 million and capital expenditures -16.30 million, giving a free cash flow of 25.48 million.

Operating Cash Flow	41.78M
Capital Expenditures	-16.30M
Free Cash Flow	25.48M
FCF Per Share	n/a

Margins

Gross margin is 37.44%, with operating and profit margins of 12.45% and 9.38%.

Gross Margin	37.44%
Operating Margin	12.45%
Pretax Margin	15.35%
Profit Margin	9.38%
EBITDA Margin	23.52%
EBIT Margin	12.45%
FCF Margin	11.67%

Dividends & Yields

FRA:VB0 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-48.61%
Shareholder Yield	-48.61%
Earnings Yield	4.35%
FCF Yield	5.41%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:VB0 has an Altman Z-Score of 0.93 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.93
Piotroski F-Score	7